ATE249821T1 - Verfahren zur verringerung der schädlichen wirkungen von bestrahlungstherapie auf tierische haut und schleimhaut - Google Patents

Verfahren zur verringerung der schädlichen wirkungen von bestrahlungstherapie auf tierische haut und schleimhaut

Info

Publication number
ATE249821T1
ATE249821T1 AT99930683T AT99930683T ATE249821T1 AT E249821 T1 ATE249821 T1 AT E249821T1 AT 99930683 T AT99930683 T AT 99930683T AT 99930683 T AT99930683 T AT 99930683T AT E249821 T1 ATE249821 T1 AT E249821T1
Authority
AT
Austria
Prior art keywords
mucosa
reducing
radiation therapy
harmful effects
animal skin
Prior art date
Application number
AT99930683T
Other languages
English (en)
Inventor
Deborah J Davenport
Kathy L Gross
Gregory K Ogilvie
Michael S Hand
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Application granted granted Critical
Publication of ATE249821T1 publication Critical patent/ATE249821T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT99930683T 1998-06-29 1999-06-24 Verfahren zur verringerung der schädlichen wirkungen von bestrahlungstherapie auf tierische haut und schleimhaut ATE249821T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/106,295 US6015798A (en) 1995-10-10 1998-06-29 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
PCT/US1999/014344 WO2000000189A1 (en) 1998-06-29 1999-06-24 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa

Publications (1)

Publication Number Publication Date
ATE249821T1 true ATE249821T1 (de) 2003-10-15

Family

ID=22310643

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99930683T ATE249821T1 (de) 1998-06-29 1999-06-24 Verfahren zur verringerung der schädlichen wirkungen von bestrahlungstherapie auf tierische haut und schleimhaut

Country Status (17)

Country Link
US (1) US6015798A (de)
EP (1) EP1091734B1 (de)
JP (2) JP4860814B2 (de)
AR (1) AR019728A1 (de)
AT (1) ATE249821T1 (de)
AU (1) AU761266B2 (de)
BR (1) BR9911663A (de)
CA (1) CA2336628C (de)
DE (1) DE69911409T2 (de)
DK (1) DK1091734T3 (de)
ES (1) ES2207951T3 (de)
MX (1) MXPA01000152A (de)
NO (1) NO329910B1 (de)
NZ (1) NZ508766A (de)
TR (1) TR200100457T2 (de)
WO (1) WO2000000189A1 (de)
ZA (1) ZA200007650B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
HK1048579A1 (zh) * 1999-09-09 2003-04-11 Societe Des Produits Nestle S.A. 改善中年以上的宠物的条件
DE60127829T2 (de) * 2000-05-01 2007-12-27 The Iams Company, Dayton Haustierfutterzusammensetzung zur verminderung der entzündungsreaktion in katzen
JP2003534019A (ja) 2000-06-01 2003-11-18 ユナイテッド フィーズ，インコーポレーテッド 動物飼料および方法
ATE492166T1 (de) * 2002-04-05 2011-01-15 Nestle Sa Zusammensetzungen und verfahren zur verbesserung von lipidassimilation in haustieren
US8841344B2 (en) 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
US6841179B2 (en) 2002-11-14 2005-01-11 The Meow Mix Company Pet food compositions comprising electrostatically charged gelatin
US6899904B2 (en) * 2002-11-14 2005-05-31 The Meow Mix Company Pet food compositions having electrostatically charged ingredient
US20060204636A1 (en) * 2002-12-23 2006-09-14 Butterwick Richard F Food for gastrointestinal health
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
BRPI0413287A (pt) * 2003-08-11 2006-10-10 Hills Pet Nutrition Inc métodos de restaurar uma função da articulação que é mais próxima do normal em um cão apresentando osteoartrite, e de eliminar a probabilidade de um cão desenvolver osteoartrite, e, uso de ácido eicosapentaenóico (epa)
US8633246B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
US8633247B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
JP2007502805A (ja) * 2003-08-18 2007-02-15 ビーティージー・インターナショナル・リミテッド 神経変性状態の処置
DK1753302T3 (da) * 2003-11-25 2011-08-15 Virginia Tech Intell Prop Sammensætning til dyrefoder og fremgangsmåde til at reducere map-kinaseaktivitet
WO2005082159A1 (ja) * 2004-02-27 2005-09-09 Nosan Corporation 食物アレルギー反応低減ペットフード
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
ES2579430T3 (es) 2004-12-30 2016-08-11 Hill's Pet Nutrition, Inc. Métodos para aumentar la calidad de vida de un animal en crecimiento
GB0504362D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
US8729133B2 (en) * 2006-02-28 2014-05-20 Cornell University Method for treating cancer
EP2214481B1 (de) 2007-10-15 2019-05-01 United Animal Health, Inc. Verfahren zur erhöhung der leistung von nachkommen
US20100323028A1 (en) * 2007-11-30 2010-12-23 Jbs United, Inc. Method and composition for treating pulmonary hemorrhage
MX367038B (es) * 2012-11-15 2019-08-02 Hills Pet Nutrition Inc Control de bola de pelo a traves de limitacion mineral en la dieta.
WO2018148763A1 (en) 2017-02-13 2018-08-16 Wintermute Biomedical, Inc. Anti-pathogenic therapeutic compositions
US12324797B2 (en) 2018-10-01 2025-06-10 Wintermute Biomedical, Inc. Therapeutic compositions
CN114828643A (zh) 2019-12-19 2022-07-29 希尔氏宠物营养品公司 用于治疗例如焦虑的具有特定不溶性纤维与可溶性纤维比率的组合物
EP4022090B1 (de) * 2019-12-19 2026-03-18 Hill's Pet Nutrition, Inc. Zusammensetzungen in verfahren zur verminderung der gefahr des auftretens und zur behandlung von hypothyreose bei hunden
JP7773543B2 (ja) * 2020-10-21 2025-11-19 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド ペットフード組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
ES2052066T3 (es) * 1988-10-31 1994-07-01 Sandoz Nutrition Ltd Mejoras en o relacionadas con compuestos organicos.
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
CA2147109A1 (en) * 1994-04-18 1995-10-19 Gregory A. Reinhart Pet food product containing omega-6 and omega-3 fatty acids and process for reducing inflammatory skin responses
US5776913A (en) * 1995-10-10 1998-07-07 Colgate Palmolive Company Therapeutic diet for metabolic abnormalities found in animals with lymphoma
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa

Also Published As

Publication number Publication date
DK1091734T3 (da) 2004-01-26
JP4860814B2 (ja) 2012-01-25
AR019728A1 (es) 2002-03-13
CA2336628C (en) 2009-03-24
CA2336628A1 (en) 2000-01-06
AU4716799A (en) 2000-01-17
NZ508766A (en) 2003-05-30
AU761266B2 (en) 2003-05-29
TR200100457T2 (tr) 2001-08-21
NO20006575L (no) 2001-02-28
NO329910B1 (no) 2011-01-24
MXPA01000152A (es) 2002-10-17
ZA200007650B (en) 2002-08-28
EP1091734B1 (de) 2003-09-17
BR9911663A (pt) 2005-12-20
DE69911409T2 (de) 2004-07-08
JP5704791B2 (ja) 2015-04-22
US6015798A (en) 2000-01-18
DE69911409D1 (de) 2003-10-23
WO2000000189A1 (en) 2000-01-06
NO20006575D0 (no) 2000-12-21
ES2207951T3 (es) 2004-06-01
JP2002519320A (ja) 2002-07-02
JP2009035533A (ja) 2009-02-19
EP1091734A1 (de) 2001-04-18

Similar Documents

Publication Publication Date Title
ATE249821T1 (de) Verfahren zur verringerung der schädlichen wirkungen von bestrahlungstherapie auf tierische haut und schleimhaut
EP0740566A4 (de) Verfahren und vorrichtung zur gleichmässigen strahlenbehandlung von herzlumen
ATE397868T1 (de) Verfahren zur verbesserung der haut und des pelzes von haustieren
ATE397408T1 (de) Verfahren zur verbesserten bilderzeugung und photodynamischen therapie
DE69529627D1 (de) Verfahren und vorrichtung zur interstitiellen bestrahlung der prostata
FI963696L (fi) Geeli ihosairauksien hoitoon ja ihon desinfiointiin
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE69926348D1 (de) System zur elektromagnetischen bestrahlung der haut
DE69813919D1 (de) Flüssigkeitgekülter Ablationskatheter und Herstellungsmethode
DE59306276D1 (de) Verfahren und anordnung zur therapie von gewebe mit ultraschall
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
ATE331522T1 (de) Zusammensetzung zur behandlung von atemwegs- und hauterkrankungen mit mindestens einem leukotrienantagonist und mindestens einem antihistaminikum
DE69828620D1 (de) Verfahren und zusammensetzungen zur vorbeugung und behandlung der chronologischer alterung der menschliches haut
ATE347360T1 (de) Verfahren zur induktion von krebszellentod und tumorregression
DE10084417T1 (de) Verfahren und Apparat zur therapeutischen Laserbehandlung
DE69227103D1 (de) Implantierbare gewebegrundlage und verfahren zur reduzierung der immunogenität
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
ATE271038T1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
EP1227821A4 (de) Therapeutische zusammensetzungen und verfahren zur verwendung davon
DE69734751D1 (de) Bestrahlungsbehandlungsvorrichtung und Verfahren
EE9800234A (et) Ravimeetod ja farmatseutiline kompositsioon
ATE237299T1 (de) Verfahren zur verbesserung der haar- und kopfhaut-gesundheit
DE60038663D1 (de) Thyristoren und verfahren zur herstellung
DE69434268D1 (de) VDMOS-Leistungsbauteil und Verfahren zur Herstellung desselben
FI951060A7 (fi) Formulaatioita ja hoitomenetelmiä

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties